Jamieson Wellness Inc. Reports Second Quarter 2026 Results

Jamieson Brands Revenue up over 18% as Consumer Demand Continues Across All Key Markets

 

TORONTO, Aug. 6, 2026 /CNW/ — Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX: JWEL) today reported its second quarter results for the period ended June 30, 2026. All amounts are expressed in Canadian dollars (“CAD”). Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other financial measures. See “Non-IFRS and Other Financial Measures” below.

 

Management Commentary

“Q2 was another strong quarter for Jamieson Wellness, with revenue growth of nearly 19% across our brands and contributions from all of our key markets,” said Mike Pilato, President and CEO of Jamieson Wellness. “A successful 6/18 campaign in China, continued innovation and strong consumer demand supported our results through the quarter, contributing to 17% growth across our branded business in the first half of 2026.

 

“As announced this afternoon, we have entered into an agreement to be acquired by Kirin Holdings Company, Limited (“Kirin”). We believe the transaction reflects the strength of the business our team has built and the value of our portfolio, and I would like to thank our team members for their ongoing dedication to serving our consumers, customers and partners.”

 

Second Quarter Highlights

  • Growth in Canada led by increased consumption and strong promotional execution at key retailers, and successful product innovation particularly in the sleep and stress categories
  • Revenue growth in China exceeded expectations, driven by strong 6/18 promotional programs and increased consumption in the Club channel
  • Digital commerce and continued execution of flagship programs in key retailers drove growth in the U.S.
  • Product innovation and successful promotional programs driving consumer traffic and conversion led growth in key International markets

 

Second Quarter Financial Results Consolidated Summary

All comparisons are with the second quarter of 2025

  • Consolidated revenue increased 17.4% to $233.8 million, driven by 18.6% growth in Jamieson Brands and 8.3% growth in Strategic Partners
  • Gross profit increased by $16.6 million to $97.4 million
  • Normalized gross profit margin3 increased by 160 basis points, mainly driven by geographic mix in the Jamieson Brands segment
  • EBITDA1 increased by $8.3 million to $38.4 million, mainly driven by higher revenues and gross profit; Adjusted EBITDA1 increased by $4.3 million or 12.3% to $39.4 million, reflecting the impact of higher sales volumes and gross profit
  • Net earnings was $18.6 million; Adjusted net earnings1 was $19.9 million, or $2.7 million higher, reflecting higher normalized earnings from operations
  • Diluted earnings per share was $0.42; Adjusted diluted earnings per share2 was $0.46

 

Summary of Segment Results

All comparisons are with the second quarter of 2025 and reflect the allocation of youtheory brand revenue to its respective branded business segment.

 

Jamieson Brands

  • Revenue increased 18.6% or $32.9 million to $210.2 million
    • Canada revenue increased by 5.7% to $91.6 million, reflecting sustained consumer demand and timing of shipments in advance of the Company’s distribution centre transition
    • China revenue increased 46.6% on a constant currency basis to $54.3 million, primarily driven by successful 6/18 promotions and continued growth across digital platforms
    • U.S. revenue increased by 21.7% on a constant currency basis to $50.1 million, reflecting the timing of pipeline fill of product innovations and continued strength in e-commerce channels
    • International revenue increased by 7.5% on a constant currency basis to $14.3 million, driven by strong consumer demand across our major markets
  • Gross profit increased by $16.4 million to $94.7 million, driven primarily by higher sales volumes
  • Gross profit margin3 increased by 90 basis points to 45.0%; normalized gross profit margin increased by 160 basis points to 45.7%, mainly driven by geographical mix and higher sales volumes in China, the Company’s highest margin market based on channel dynamics
  • Adjusted EBITDA1 increased by $4.0 million to $37.5 million, driven by higher gross profit; Adjusted EBITDA margin2 decreased by 110 basis points to 17.8%, mainly driven by higher SG&A due to performance marketing campaign investments

 

Strategic Partners

  • Revenue increased 8.3% or $1.8 million to $23.6 million, driven by customer ordering patterns and new programs with key customers
  • Gross profit increased 5.5% to $2.7 million, driven by higher sales volumes; gross profit margin decreased by 30 basis points to 11.5%, mainly driven by customer mix
  • Adjusted EBITDA1 increased by 17.0% to $1.9 million, mainly due to higher gross profit; Adjusted EBITDA margin2 was 8.2%

 

Balance Sheet and Cash Flow from Operations

All comparisons are with the second quarter of 2025

  • As at June 30, 2026, the Company had approximately $383.3 million in cash and available revolving and swingline facilities and net debt1 of $416.7 million
  • The Company generated $1.8 million in cash from operations compared to $11.4 million generated in Q2 2025
  • Cash from operating activities before working capital considerations was $25.9 million, $7.2 million higher than prior year, mainly due to revenue and earnings growth
  • Cash invested in working capital increased by $16.8 million mainly due to the timing of vendor payments, resulting in a significant change in accounts payable and accrued liabilities, partially offset by lower investments in inventories and receivables

1 This is a non-IFRS financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS financial measure.

2 This is a non-IFRS ratio. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each non-IFRS ratio.

3 This is a supplementary financial measure. See the “Non-IFRS and Other Financial Measures” section of this press release for more information on each supplementary financial measure.

 

Withdrawal of Financial Guidance for Fiscal 2026

In light of the earlier announcement today of the Company entering into a definitive arrangement agreement (the “Arrangement Agreement”) with Kirin, pursuant to which Kirin has agreed to acquire all of the issued and outstanding common shares (the “Shares”) of the Company (the “Transaction”) at a price of CAD $45.75 per Share in cash, the Company is withdrawing its previously issued financial guidance for the 2026 fiscal year.

The announced Transaction represents a significant strategic shift that will impact the Company’s capital structure and financial profile. Due to the inherent unpredictability of the precise timing of the closing, transaction-related expenses, integration costs and the ultimate financial impact of the Transaction, management believes it is prudent to withdraw its outlook at this time.

 

Declaration of Second Quarter Dividend

The Board of Directors of the Company authorized a 2.0 cent or an 8.7% increase in the quarterly dividend and declared a cash dividend for the second quarter of 2026:

  • $0.25 per common share, or approximately $10.4 million in the aggregate
  • Paid on September 15, 2026 to all common shareholders of record at the close of business on August 31, 2026
  • The Company has designated this dividend as an “eligible dividend” for the purposes of the Income Tax Act (Canada)

 

Consolidated Financial Statements and Management’s Discussion and Analysis

The Company’s unaudited condensed consolidated interim financial statements and accompanying notes as at and for the three and six months ended June 30, 2026 and related MD&A are available under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Investor Relations section of the Company’s website at https://investors.jamiesonwellness.com.

 

Conference Call

As noted earlier today, in light of the recently announced Transaction, the regularly scheduled conference call to discuss the Company’s second quarter 2026 results has been cancelled.

 

About Jamieson Wellness

Jamieson Wellness is dedicated to Inspiring Better Lives Every Day with its portfolio of innovative natural health brands. Established in 1922, the Jamieson brand is Canada’s #1 vitamins, minerals and supplements (“VMS”) brand. The Company’s youtheory brand, acquired in 2022, is an established and growing lifestyle brand in the U.S. Combined, these global brands are available in more than 50 countries worldwide. The Company also offers a variety of innovative VMS products as well as sports nutrition products to consumers in Canada with its Progressive, Smart Solutions, Iron Vegan and Precision brands. The Company is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. For more information, please visit jamiesonwellness.com.

Jamieson Wellness’ head office is located at 1 Adelaide Street East Suite 2200, Toronto, Ontario, Canada.

 

Forward-Looking Information

This press release may contain forward-looking information within the meaning of applicable securities legislation. Such information includes, but is not limited to, statements related to statements regarding the Transaction, including the proposed timing and completion of the Transaction,. Words such as “expect”, “anticipate”, “intend”, “may”, “will”, “estimate” and variations of such words and similar expressions are intended to identify such forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances, which could prove to be incorrect.

 

The forward-looking information in this press release is based on a number of assumptions, including our ability to complete the Transaction on the terms and conditions contemplated, or on the timing, currently contemplated. The forward-looking information in this press release is also subject to a number of risks and uncertainties, many of which are beyond the Company’s control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include the factors discussed under “Risk Factors” in the Company’s Annual Information Form dated March 31, 2026 and under the “Risk Factors” section in the MD&A filed today, August 6, 2026. The Company cautions that the forgoing list of assumptions and risks is not exhaustive and other factors could also adversely affect the Company’s results.

 

The forward-looking information in this press release is given as of the date of this press release. The Company does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

 

Jamieson Wellness Inc.
Selected Consolidated Financial Information
In thousands of Canadian dollars, except share and per share amounts

Three months ended

Six months ended

June 30

June 30

2026

2025

2026

2025

Revenue

233,844

199,109

403,594

345,072

Cost of sales

136,452

118,295

237,117

209,038

Gross profit

97,392

80,814

166,477

136,034

Gross profit margin

41.6 %

40.6 %

41.2 %

39.4 %

Selling, general and administrative expenses

65,552

55,346

118,105

104,933

Share-based compensation

2,226

2,078

4,595

4,165

Earnings from operations

29,614

23,390

43,777

26,936

Operating margin

12.7 %

11.7 %

10.8 %

7.8 %

Foreign exchange gain

(3,393)

(1,749)

(4,624)

(1,245)

Interest expense and other financing costs

7,555

4,771

12,620

9,679

Accretion on preferred shares

1,155

3,427

Earnings before income taxes

25,452

19,213

35,781

15,075

Provision for income taxes

6,842

5,385

7,571

3,761

Net earnings

18,610

13,828

28,210

11,314

Net earnings attributable to:

Shareholders

17,948

13,071

26,757

10,625

Non-controlling interests

662

757

1,453

689

18,610

13,828

28,210

11,314

Adjusted net earnings

19,921

17,267

27,341

23,215

EBITDA

38,401

30,118

58,822

37,915

Adjusted EBITDA

39,425

35,100

61,853

54,166

Adjusted EBITDA margin

16.9 %

17.6 %

15.3 %

15.7 %

Weighted average number of shares

Basic

41,481,638

41,712,207

41,432,789

41,845,278

Diluted

43,020,022

43,065,916

42,893,721

43,104,101

Earnings per share attributable to common shareholders:

Basic, earnings per share

0.43

0.31

0.65

0.25

Diluted, earnings per share

0.42

0.30

0.62

0.25

Adjusted diluted, earnings per share

0.46

0.40

0.64

0.54

Jamieson Wellness Inc.
Consolidated Statements of Financial Position
In thousands of Canadian dollars

June 30,
2026

December 31,
2025

Assets

Current assets

Cash

24,314

41,225

Accounts receivable

157,042

199,245

Inventories

256,977

203,083

Derivatives

1,270

486

Prepaid expenses and other current assets

9,833

7,303

Income taxes recoverable

5,819

455,255

451,342

Non-current assets

Property, plant and equipment

122,783

117,342

Goodwill

285,510

279,644

Intangible assets

366,954

362,753

Deferred income tax

3,113

3,951

Total assets

1,233,615

1,215,032

Liabilities

Current liabilities

Accounts payable and accrued liabilities

123,535

155,266

Income taxes payable

1,742

2,894

Derivatives

2,251

3,971

Current portion of other long-term liabilities

6,065

12,014

133,593

174,145

Long-term liabilities

Long-term debt

441,000

414,597

Post-retirement benefits

1,343

1,282

Deferred income tax

71,119

68,855

Other long-term liabilities

30,289

26,642

Total liabilities

677,344

685,521

Equity

Share capital

340,021

333,347

Warrants

14,705

14,705

Contributed surplus

26,104

27,494

Retained earnings

98,106

90,374

Accumulated other comprehensive income

30,587

19,498

Total shareholders’ equity

509,523

485,418

Non-controlling interests

46,748

44,093

Total equity

556,271

529,511

Total liabilities and equity

1,233,615

1,215,032

 

Non-IFRS and Other Financial Measures

This press release makes reference to certain financial measures, including non-IFRS financial measures that are historical, non-IFRS measures that are forward-looking, non-GAAP ratios and supplementary financial measures. Management uses these financial measures for purposes of comparison to prior periods and development of future projections and earnings growth prospects. This information is also used by management to measure the profitability of ongoing operations and to analyze the Company’s business performance and trends. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company’s results of operations from management’s perspective. Accordingly, they should not be considered in isolation nor as a substitute for analysis of the Company’s financial information reported under IFRS. The Company uses the following non-IFRS financial measures: “EBITDA”, “Adjusted EBITDA” and “Adjusted net earnings”, the most directly comparable financial measure for each that is disclosed in its financial statements being net earnings, “normalized gross profit”, “normalized SG&A”, “normalized earnings from operations”, “cash from operating activities before working capital considerations” and “net debt”, the most directly comparable financial measures for each that is disclosed in its financial statements being gross profit, SG&A, earnings from operations, cash flows from operating activities, and long-term debt, respectively, the following non-IFRS ratios: “Adjusted EBITDA margin”, “Adjusted diluted earnings per share”, “normalized gross profit margin”, “normalized operating margin”, and the following supplementary financial measures: “gross profit margin” and “operating margin” to provide supplemental measures of the Company’s operating performance and thus highlight trends in the Company’s core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management also uses non-IFRS and supplementary financial measures in order to prepare annual operating budgets and to determine components of management compensation. For an explanation of the composition of each such measure and the usefulness and additional uses of each by management, see the “How we Assess the Performance of our Business” section of the MD&A, which is incorporated by reference. See below for a quantitative reconciliation of each non-IFRS financial measure to its most directly comparable financial measure disclosed in the Company’s financial statements to which the measure relates.

 

The following tables provide a quantitative reconciliation of net earnings to EBITDA, Adjusted EBITDA, and Adjusted net earnings, as well as gross profit to normalized gross profit, SG&A to normalized SG&A, earnings from operations to normalized earnings from operations and net debt, each of which are non-IFRS financial measures (see the “Non-IFRS and Other Financial Measures” of this press release for further information on each non-IFRS financial measure) for the three and six months ended June 30, 2026.

 

Jamieson Wellness Inc.
Segment Information
In thousands of Canadian dollars, except as otherwise noted

Jamieson Brands

Three months ended
June 30

2026

2025

$ Change

% Change

Revenue

210,248

177,317

32,931

18.6 %

Gross profit

94,688

78,251

16,437

21.0 %

Distribution centre transition (2)

1,331

1,331

100.0 %

Normalized gross profit

96,019

78,251

17,768

22.7 %

Gross profit margin

45.0 %

44.1 %

0.9 %

Normalized gross profit margin

45.7 %

44.1 %

1.6 %

Share-based compensation (1)

2,226

2,078

148

7.1 %

Selling, general and administrative expenses

63,989

53,767

10,222

19.0 %

IT system implementation (3)

(425)

(3,796)

3,371

88.8 %

Legal and other (4)

(435)

(857)

422

49.2 %

Normalized selling, general and administrative expenses

63,129

49,114

14,015

28.5 %

Earnings from operations

28,473

22,406

6,067

27.1 %

Distribution centre transition (2)

1,331

1,331

IT system implementation (3)

425

3,796

(3,371)

(88.8 %)

Legal and other (4)

435

857

(422)

(49.2 %)

Normalized earnings from operations

30,664

27,059

3,605

13.3 %

Operating margin

13.5 %

12.6 %

0.9 %

Normalized operating margin

14.6 %

15.3 %

(0.7 %)

Adjusted EBITDA

37,501

33,455

4,046

12.1 %

Adjusted EBITDA margin

17.8 %

18.9 %

(1.1 %)

Strategic Partners

Three months ended
June 30

2026

2025

$ Change

% Change

Revenue

23,596

21,792

1,804

8.3 %

Gross profit

2,704

2,563

141

5.5 %

Gross profit margin

11.5 %

11.8 %

(0.3 %)

Selling, general and administrative expenses

1,563

1,579

(16)

(1.0 %)

Earnings from operations

1,141

984

157

16.0 %

Operating margin

4.8 %

4.5 %

0.3 %

Adjusted EBITDA

1,924

1,645

279

17.0 %

Adjusted EBITDA margin

8.2 %

7.5 %

0.7 %

Jamieson Brands

Six months ended
June 30

2026

2025

$ Change

% Change

Revenue

362,122

308,698

53,424

17.3 %

Gross profit

161,313

132,041

29,272

22.2 %

Distribution centre transition (2)

1,331

1,331

100.0 %

IT system implementation (3)

1,023

(1,023)

(100.0 %)

Normalized gross profit

162,644

133,064

29,580

22.2 %

Gross profit margin

44.5 %

42.8 %

0.0 %

1.7 %

Normalized gross profit margin

44.9 %

43.1 %

0.0 %

1.8 %

Share-based compensation (1)

4,595

4,165

430

10.3 %

Selling, general and administrative expenses

114,846

101,807

13,039

12.8 %

IT system implementation (3)

(1,044)

(8,082)

7,038

87.1 %

Donations (5)

(3,118)

3,118

100.0 %

Legal and other (4)

(685)

(882)

197

22.3 %

Normalized selling, general and administrative expenses

113,117

89,725

23,392

26.1 %

Earnings from operations

41,872

26,069

15,803

60.6 %

IT system implementation (3)

1,044

9,105

(8,061)

(88.5 %)

Distribution centre transition (2)

1,331

1,331

100.0 %

Donations (5)

3,118

(3,118)

(100.0 %)

Legal and other (4)

685

882

(197)

(22.3 %)

Normalized earnings from operations

44,932

39,174

5,758

14.7 %

Operating margin

11.6 %

8.4 %

3.2 %

Normalized operating margin

12.4 %

12.7 %

(0.3 %)

Adjusted EBITDA

58,563

51,728

6,835

13.2 %

Adjusted EBITDA margin

16.2 %

16.8 %

(0.6 %)

Strategic Partners

Six months ended
June 30

2026

2025

$ Change

% Change

Revenue

41,472

36,374

5,098

14.0 %

Gross profit

5,164

3,993

1,171

29.3 %

IT system implementation (3)

226

(226)

(100.0 %)

Normalized gross profit

5,164

4,219

945

22.4 %

Gross profit margin

12.5 %

11.0 %

1.5 %

Normalized gross profit margin

12.5 %

11.6 %

0.9 %

Selling, general and administrative expenses

3,259

3,126

133

4.3 %

Earnings from operations

1,905

867

1,038

119.7 %

IT system implementation (3)

226

(226)

(100.0 %)

Normalized earnings from operations

1,905

1,093

812

74.3 %

Operating margin

4.6 %

2.4 %

2.2 %

Normalized operating margin

4.6 %

3.0 %

1.6 %

Adjusted EBITDA

3,290

2,438

852

34.9 %

Adjusted EBITDA margin

7.9 %

6.7 %

1.2 %

Reconciliation of Non-IFRS Financial Measures
In thousands of Canadian dollars

Three months ended

Six months ended

June 30

June 30

2026

2025

2026

2025

Net earnings:

18,610

13,828

28,210

11,314

Add:

Provision for income taxes

6,842

5,385

7,571

3,761

Interest expense and other financing costs

7,555

4,771

12,620

9,679

Accretion on preferred shares

1,155

3,427

Depreciation of property, plant, and equipment

3,913

3,474

7,470

6,729

Amortization of intangible assets

1,481

1,505

2,951

3,005

Earnings before interest, taxes, depreciation, and amortization (EBITDA)

38,401

30,118

58,822

37,915

Share-based compensation (1)

2,226

2,078

4,595

4,165

Foreign exchange gain

(3,393)

(1,749)

(4,624)

(1,245)

Distribution centre transition (2)

1,331

1,331

IT system implementation (3)

425

3,796

1,044

9,331

Donations (5)

3,118

Legal and other (4)

435

857

685

882

Adjusted EBITDA

39,425

35,100

61,853

54,166

Provision for income taxes

(6,842)

(5,385)

(7,571)

(3,761)

Interest expense and other financing costs

(7,555)

(4,771)

(12,620)

(9,679)

Financing costs on renewal of credit facility

2,173

2,173

Depreciation of property, plant, and equipment

(3,913)

(3,474)

(7,470)

(6,729)

Amortization of intangible assets

(1,481)

(1,505)

(2,951)

(3,005)

Share-based compensation (1)

(2,226)

(1,956)

(4,516)

(3,921)

Tax deduction from vesting of certain share-based awards

(19)

(2,002)

(708)

Tax effect of normalization adjustments

340

(723)

445

(3,148)

Adjusted net earnings

19,921

17,267

27,341

23,215

Three months ended

Six months ended

June 30

June 30

2026

2025

2026

2025

Gross profit

97,392

80,814

166,477

136,034

IT system implementation (3)

1,249

Distribution centre transition (2)

1,331

1,331

Normalized gross profit

98,723

80,814

167,808

137,283

Normalized gross profit margin

42.2 %

40.6 %

41.6 %

39.8 %

Selling, general and administrative expenses

65,552

55,346

118,105

104,933

IT system implementation (3)

(425)

(3,796)

(1,044)

(8,082)

Donations (5)

(3,118)

Legal and other (4)

(435)

(857)

(685)

(882)

Normalized selling, general and administrative expenses

64,692

50,693

116,376

92,851

Earnings from operations

29,614

23,390

43,777

26,936

Distribution centre transition (2)

1,331

1,331

Donations (5)

3,118

IT system implementation (3)

425

3,796

1,044

9,331

Legal and other (4)

435

857

685

882

Normalized earnings from operations

31,805

28,043

46,837

40,267

Normalized operating margin

13.6 %

14.1 %

11.6 %

11.7 %

(1)

Our share-based compensation expense pertains to our LTIP (refer to “Share-based compensation”), with stock option, PSU, RSU and DSU expenses, along with associated payroll taxes.

(2)

Includes costs related to the transition of our existing distribution centre to a larger and more efficient facility.

(3)

Mainly pertains to development and post implementation start-up costs associated with our IT system implementation to augment our system infrastructure. Unlike other system improvement projects with costs capitalized, due to its cloud-based nature, these system implementation costs are expensed accordingly.

(4)

Includes professional service fees relating to completed due diligence costs for an unsuccessful acquisition and other non-recurring expenses primarily relating to non-operational legal costs.

(5)

Includes cash and in-kind donations to support communities adjacent to our Irvine, California facility impacted by the wildfires in 2025.

Reconciliation of Net Debt
In thousands of Canadian dollars

($ in 000’s)

As at June 30,

As at December 31,

2026

2025

Long-term debt

441,000

414,597

Cash

(24,314)

(41,225)

Net debt

416,686

373,372

SOURCE Jamieson Wellness Inc.